InsidersTradesSigma
아스타 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the 아스타 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 아스타 has logged 69 public disclosures. Market capitalisation: €99.4bn. The latest transaction was disclosed on 23 June 2026 (Other). Among the most active insiders: 품에자산운용. Every trade is free.
69
Insider Decl.
0
Thresholds
·
47 ops.
Buy Volume
·
0 ops.
Sell Volume
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 20,881 of 26,212 companies
30.9
score / 100
Value25
Quality37
FCF yld-3.4%
Earn yld-3.3%
EV/EBITDA·
ROE-50%
Gross mgn48%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 23 June 2026
Declarations69 total
25 of 69 declarations
About 아스타
아스타 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and commercialization of innovative pharmaceutical products.